We use cookies to enable the functions required for this website, such as login or a shopping cart. You can find more information in our privacy policy.
Jay P. Malmquist, DMD, FACD, FICD, FAO, is an oral and maxillofacial surgeon who maintains a private practice in Portland, Oregon. He is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American College of Dentists, the International College of Dentists, the Academy of Osseointegration, and the American College of Oral and Maxillofacial Surgeons. He was the first treasurer and first president of the American Association of Oral and Maxillofacial Surgeons from the Pacific Northwest and currently serves as chairman of the Foundation of Oral Rehabilitation. He has written numerous articles and book chapters on bone grafting, implant surgery, and tissue regeneration and has lectured internationally on these subjects in more than 20 countries. Dr Malmquist is a former professor of Oral and Maxillofacial Surgery at Oregon Health Sciences University, where he taught for 27 years.
Events
The 14th International Symposium on Periodontics and Restorative Dentistry (ISPRD)
9. Jun 2022 — 12. Jun 2022Boston Marriott Copley Place, Boston, MA, United States of America
Speakers: Tara Aghaloo, Edward P. Allen, Evanthia Anadioti, Wael Att, Vinay Bhide, Markus Blatz, Scotty Bolding, Lorenzo Breschi, Jeff Brucia, Daniel Buser, Luigi Canullo, Daniele Cardaropoli, Stephen J. Chu, Donald Clem, Christian Coachman, Lyndon F. Cooper, Daniel Cullum, Lee Culp, José Carlos Martins da Rosa, Sergio De Paoli, Marco Degidi, Nicholas Dello Russo, Serge Dibart, Joseph P. Fiorellini, Mauro Fradeani, Stuart J. Froum, David Garber, Maria L. Geisinger, William Giannobile, Luca Gobbato, Ueli Grunder, Galip Gürel, Chad Gwaltney, Christoph Hämmerle, Robert A. Horowitz, Marc Hürzeler, David Kim, Gregg Kinzer, Christopher Köttgen, Ina Köttgen, Purnima S. Kumar, Burton Langer, Lydia Legg, Pascal Magne, Kenneth A. Malament, Jay Malmquist, George Mandelaris, Pamela K. McClain, Michael K. McGuire, Mauro Merli, Konrad H. Meyenberg, Craig M. Misch, Julie A. Mitchell, Marc L. Nevins, Myron Nevins, Michael G. Newman, Miguel A. Ortiz, Jacinthe M. Paquette, Stefano Parma-Benfenati, Michael A. Pikos, Giulio Rasperini, Pamela S. Ray, Christopher R. Richardson, Isabella Rocchietta, Marisa Roncati, Marco Ronda, Paul S. Rosen, Maria Emanuel Ryan, Irena Sailer, Maurice Salama, David M. Sarver, Takeshi Sasaki, Todd Scheyer, Massimo Simion, Michael Sonick, Sergio Spinato, Dennis P. Tarnow, Lorenzo Tavelli, Douglas A. Terry, Tiziano Testori, Carlo Tinti, Istvan Urban, Hom-Lay Wang, Robert Winter, Giovanni Zucchelli
Quintessence Publishing Co., Inc. USA
This author's journal articles
The International Journal of Oral & Maxillofacial Implants, 1/2015
DOI: 10.11607/jomi.3977, PubMed ID (PMID): 25615925Pages 202-207, Language: EnglishMisch, Craig M. / Jensen, Ole T. / Pikos, Michael A. / Malmquist, Jay P.
Purpose: This retrospective study evaluated the use of a composite graft of recombinant human bone morphogenetic protein-2 (rhBMP-2) and particulate mineralized bone allograft protected by a titanium mesh for vertical bone augmentation.
Materials and Methods: A review of data on patients from four oral and maxillofacial surgery practices in the United States who required vertical augmentation prior to implant treatment was conducted. Vertical augmentation was accomplished with rhBMP-2 in an absorbable collagen sponge (ACS) carrier and particulate allograft. Cone beam computed tomography was used to measure vertical bone gains using this technique.
Results: Sixteen vertical ridge augmentation procedures were performed in 15 patients. The maximum vertical bone gains ranged from 4.4 to 16.3 mm. The average maximum vertical bone gain was 8.53 mm. The procedure allowed implant placement in all patients. Forty implants were inserted into the grafted ridges after a minimum of 6 months of healing. All implants integrated and were used for prosthetic support.
Conclusion: This study suggests that rhBMP-2/ACS and particulate mineralized bone allograft protected by a titanium mesh offers favorable vertical bone gains to allow dental implant placement.
Keywords: cone beam computed tomography, recombinant human bone morphogenetic protein-2, titanium mesh, vertical bone augmentation
The International Journal of Oral & Maxillofacial Implants, 6/1994
Pages 644-652, Language: EnglishFritz, Michael E. / Malmquist, Jay / Koth, David / Jeffcoat, Marjorie / Hardwick, Ross / Braswell, Laura D. / Lemons, Jack
The use of guided bone regeneration to fill large bone voids in the mandible created through en bloc resection and chronic granulation in three primates was examined. In each of three animals, en bloc resections of implants and surrounding bone were done bilaterally (10 × 8 mm and 16 × 8 mm). Tissues were allowed to heal in a chronic state (for 6 months). A reinforced expanded polytetrafluorethylene (e-PTFE) membrane was then surgically placed over each defect site to be followed for 1 year postsurgically. Two of the six membranes became infected during the first month and were removed. The remaining four membranes were removed en bloc after 1 year. Bone regeneration (greater than 90% of the defect) was observed clinically, and subtraction radiology demonstrated bone gain of between 544 and 733 mg. Histomorphometry after fluorescent labeling demonstrated a mean growth rate of 2.77 µm/wk for all sites measured, and a decrease in the number of osteons from the new bone at the crest to the mature bone at the base of the original defect. This study gives evidence that substantial quantities of new bone can be produced in atrophic mandibles and that this regenerated bone exhibits normal maturation dynamics.
Keywords: guided bone regeneration, mandibular defects, monkeys